Combination Therapy with VELCADE plus Melphalan & Prednisone
By Jesús San Miguel
At the 2005 annual meeting of the American Society of Hematology, Dr. Jesús F. San Miguel presented interim data on the ongoing GEM/PETHEMA study of VELCADE® (bortezomib) plus melphalan and prednisone (V-MP) in elderly, previous
Be the first to comment